Key Points
- Liquidia insider Jason Adair sold 688 shares at an average price of $43.19, generating $29,714.72. The sale was conducted under a Rule 10b5-1 plan to cover tax withholding, reducing his ownership by 0.39% to 177,269 shares.
- Liquidia’s shares opened at $45.72, with a market capitalization of approximately $4.09 billion. The stock has traded between $22.05 and $93.61 over the past year, while its latest quarterly revenue surged 1,842.1% year over year to $171.68 million.
- Analyst sentiment is mixed, with a consensus “Hold” rating and an average price target of $72.85. Institutional investors own approximately 64.54% of the company.
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Jason Adair sold 688 shares of the business's stock in a transaction dated Monday, October 26th. The shares were sold at an average price of $43.19, for a total transaction of $29,714.72. Following the completion of the sale, the insider directly owned 177,269 shares of the company's stock, valued at approximately $7,656,248.11. This trade represents a 0.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Jason Adair also recently made the following trade(s):
- On Monday, October 12th, Jason Adair sold 7,301 shares of Liquidia stock. The stock was sold at an average price of $28.48, for a total transaction of $207,932.48.
- On Friday, August 21st, Jason Adair sold 73,631 shares of Liquidia stock. The stock was sold at an average price of $69.09, for a total transaction of $5,087,165.79.
Liquidia Stock Performance
Shares of NASDAQ:LQDA opened at $45.72 on Thursday. The firm has a market cap of $4.09 billion, a PE ratio of 33.37, a price-to-earnings-growth ratio of 0.37 and a beta of 0.61. The firm's 50 day simple moving average is $54.12 and its 200-day simple moving average is $54.22. Liquidia Corporation has a one year low of $22.05 and a one year high of $93.61. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.12 and a current ratio of 2.31.
Liquidia (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.02). The company had revenue of $171.68 million for the quarter, compared to the consensus estimate of $168.48 million. Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The business's revenue was up 1842.1% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.49) EPS. As a group, equities analysts predict that Liquidia Corporation will post 2.05 EPS for the current year.
Wall Street Analysts Forecast Growth
LQDA has been the topic of several research reports. Weiss Ratings upgraded Liquidia from a "sell (d-)" rating to a "hold (c)" rating in a report on Tuesday, September 22nd. HC Wainwright lifted their target price on Liquidia from $58.00 to $65.00 and gave the company a "buy" rating in a research report on Thursday, October 15th. Wedbush set a $58.00 target price on Liquidia in a report on Friday, October 2nd. Bank of America increased their price target on Liquidia from $79.00 to $92.00 and gave the stock a "neutral" rating in a research report on Thursday, August 13th. Finally, Wall Street Zen lowered Liquidia from a "buy" rating to a "hold" rating in a research note on Saturday, October 3rd. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $72.85.
Get Our Latest Analysis on LQDA
Institutional Investors Weigh In On Liquidia
A number of hedge funds have recently made changes to their positions in the stock. Pinnacle Wealth Planning Services Inc. boosted its position in Liquidia by 26.2% during the third quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. Globeflex Capital L P purchased a new position in Liquidia in the second quarter valued at about $175,000. Nykredit A S bought a new position in Liquidia in the second quarter worth about $177,000. Sterling Capital Management LLC raised its holdings in Liquidia by 839.1% in the third quarter. Sterling Capital Management LLC now owns 2,329 shares of the company's stock worth $70,000 after purchasing an additional 2,081 shares in the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in Liquidia by 13.8% in the third quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company's stock worth $80,000 after purchasing an additional 320 shares in the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.
Liquidia Company Profile
(
Get Free Report)
Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.
Liquidia's lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
